Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FDAEA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,727
Award facts
- Contract value 100% obligated
- $19,726.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $19,726.88 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 8, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 and extends through December 2026.
Zepbound (semaglutide) is a GLP-1 receptor agonist medication used for weight management in adults with obesity or overweight conditions. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems through its DLA contracts. The SPE2DX prime vendor contract provides a flexible vehicle for delivering specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains to support Defense Health Agency and other federal healthcare programs globally. This delivery order reflects ongoing pharmaceutical support for federal beneficiaries within the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FDAEA?
SPE2DB25FDAEA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FDAEA worth?
The government has obligated $19,727 on SPE2DB25FDAEA.
Is contract SPE2DB25FDAEA an order under another contract?
Yes. SPE2DB25FDAEA is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAEA competed?
The extent of competition for SPE2DB25FDAEA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award